ReviewFrontiers in oncology2019

Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer.

Julie-Ann Hulin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.